Eaton Vance Worldwide Health Sciences Fund Class A (ETHSX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD
13.44
+0.07 (0.52%)
At close: Jun 4, 2025
-4.75%
Fund Assets 1.02B
Expense Ratio 1.17%
Min. Investment $1,000
Turnover n/a
Dividend (ttm) 0.62
Dividend Yield 4.64%
Dividend Growth 92.11%
Payout Frequency Annual
Ex-Dividend Date n/a
Previous Close 13.37
YTD Return 3.86%
1-Year Return -0.40%
5-Year Return 38.50%
52-Week Low 12.15
52-Week High 15.66
Beta (5Y) n/a
Holdings 49
Inception Date Jul 26, 1985

About ETHSX

ETHSX was founded on 1985-07-26 and is currently managed by Kritzer,Pandolfi. The Fund's investment strategy focuses on GL Health/Biotech with 1.22% total expense ratio. The minimum amount to invest in Eaton Vance Growth Trust: Eaton Vance Worldwide Health Sciences Fund; Class A Shares is $1,000 on a standard taxable account. Eaton Vance Growth Trust: Eaton Vance Worldwide Health Sciences Fund; Class A Shares seeks long-term capital growth by investing in a global, diversified portfolio of securities of health science companies. ETHSX normally invests at least 80% of its assets in securities of companies primarily engaged in the discovery, development, production or distribution of products related to health care.

Fund Family Eaton Vance Class A
Category Health
Performance Rating Above Average
Risk Rating Below Average
Stock Exchange NASDAQ
Ticker Symbol ETHSX
Share Class Class A
Index MSCI World/Health Care NR

Performance

ETHSX had a total return of -0.40% in the past year, including dividends. Since the fund's inception, the average annual return has been 6.90%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol Share Class Expense Ratio
EIHSX Class I 0.92%
ERHSX Class R 1.42%
ECHSX Class C 1.92%

Top 10 Holdings

52.10% of assets
Name Symbol Weight
Eli Lilly and Company LLY 10.52%
AbbVie Inc. ABBV 6.71%
AstraZeneca PLC AZN 5.03%
UnitedHealth Group Incorporated UNH 4.89%
Roche Holding AG ROG 4.80%
Abbott Laboratories ABT 4.58%
Bristol-Myers Squibb Company BMY 4.24%
Novo Nordisk A/S NOVO.B 4.15%
Johnson & Johnson JNJ 3.64%
Thermo Fisher Scientific Inc. TMO 3.55%
View More Holdings

Dividend History

Ex-Dividend Amount Pay Date
Dec 5, 2024 $0.623 Dec 6, 2024
Dec 7, 2023 $0.3243 Dec 8, 2023
Dec 8, 2022 $0.5623 Dec 9, 2022
Dec 9, 2021 $1.2056 Dec 10, 2021
Dec 10, 2020 $0.9548 Dec 11, 2020
Dec 3, 2019 $0.6671 Dec 4, 2019
Full Dividend History